A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation

Documenti analoghi

• A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation
  di: Antonio Vallarola, et al.
  Pubblicazione: (2020-11-01)
• New Insights on the Mechanisms of Disease Course Variability in ALS from Mutant SOD1 Mouse Models
  di: Nardo, Giovanni, et al.
  Pubblicazione: (2016)
• Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP).
  di: Donate, L. E., et al.
  Pubblicazione: (1994)
• Exploring the chemical space of the lysine-binding pocket of the first kringle domain of hepatocyte growth factor/scatter factor (HGF/SF) yields a new class of inhibitors of HGF/SF-MET binding
  di: Sigurdardottir, A. G., et al.
  Pubblicazione: (2015)
• RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue
  di: Vallarola, Antonio, et al.
  Pubblicazione: (2018)